Coronavirus disease 2019 and preterm birth: A systematic review and meta analysis

Zhibek Oralkhan 1 * , Gulmira Zhurabekova 1, Ibrahim A Abdelazim 2, Aidana Pazylbek 1
More Detail
1 Department of Gynecology, Al-Farabi Kazakh National University, Almaty, Kazakhstan
2 Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
* Corresponding Author
J CLIN MED KAZ, Volume 18, Issue 5, pp. 54-58. https://doi.org/10.23950/jcmk/11230
OPEN ACCESS 1449 Views 839 Downloads
Download Full Text (PDF)

ABSTRACT

Background: The COVID-19 pandemic is a challenge for the healthcare system in most countries and its association with adverse pregnancy outcomes, especially preterm birth is controversial. The present study aim to understand the relation between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of pregnancy and outcome of preterm birth. Methods: A search was performed in Cochrane Library, PubMed Scopus, E library and local databases up to 30 April, 2021. Searching strategy was used PICOS (Population, Intervention, Comparison and Outcomes, study design) framework. Study group included COVID-19 pregnant patients compared with healthy pregnant women. Main outcome was perform birth(<37 gestational week). The data were extracted from two authors and statistical analyses carried out using Review Manager (RevMan). Random-effects meta-analysis was conducted to calculate odds ratios (ORs) and weighted mean differences with 95% confidence intervals (CI). Results: Twenty six cohort studies involving 436695 pregnant participants were included in this study. Covid 19 was associated with significantly increased risk of preterm birth [OR =1.30 (1.20–1.39); p =0.02; I2 =41% ].
Conclusion: COVID-19 may be associated with increased risks of preterm birth, it is important to further understand the mechanism that explain the association and identify effective prevention methods to avoid Covid19 caused adverse pregnancy outcome.
Keywords: Coronavirus disease 2019 (COVID-19), Preterm birth, SARS-CoV-2.

CITATION

Oralkhan Z, Zhurabekova G, Abdelazim IA, Pazylbek A. Coronavirus disease 2019 and preterm birth: A systematic review and meta analysis. J CLIN MED KAZ. 2021;18(5):54-8. https://doi.org/10.23950/jcmk/11230

REFERENCES

  • Semenova Y, Glushkova N, Pivina L, Khismetova Z, Zhunussov Y, Sandybaev M, Ivankov A. Epidemiological Characteristics and Forecast of COVID-19 Outbreak in the Republic of Kazakhstan. J Korean Med Sci. 2020;35(24):e227. doi: 10.3346/jkms.2020.35.e227.
  • Lokshin V.N., Sharman A.T., Mirzakhmetova D.D., Terlikbaeva A.T., Aimbetova A.R., Karibaeva Sh.K., Urazymbetova K.A. The modern organizational principles of specialized medical care for pregnant and puerperant women during the coronavirus pandemic in the Republic of Kazakhstan. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2020; 12: 34-43 (in Russian) doi:10.18565/aig.2020.12.34-43
  • Belokrinitskaya T.E., Artymuk N.V., Filippov O.S., Frolova N.I. Clinical course, maternal and perinatal outcomes of 2019 novel coronavirus infectious disease (COVID-19) in pregnant women in Siberia and Far East Akusherstvo i Ginekologiya/ Obstetrics and gynecology. 2021; 2: 48-54 (in Russian).doi:10.18565/aig.2021.2.48-54
  • Lokken EM, Taylor GG, Huebner EM, Vanderhoeven J, Hendrickson S, Coler B, et al. Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients. Am J Obstet Gynecol. 2021; S0002-9378(21)00098-3. doi: 10.1016/j.ajog.2021.02.011.
  • World Health Organization. Summary of probable SARS cases with onset of illness from November 2002 to 31 July 2003 [EB/OL]. (2004-04)[2020-01-19]. https://www.who.int/csr/sars/country/table2004_04_21 /en/.
  • Narang K, Enninga EAL, Gunaratne MDSK, Ibirogba ER, Trad ATA, Elrefaei A, Theiler RN, Ruano R, Szymanski LM, Chakraborty R, Garovic VD. SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review. Mayo Clin Proc. 2020;95(8):1750-1765. doi: 10.1016/j.mayocp.2020.05.011.
  • Hudak ML. Consequences of the SARS-CoV-2 pandemic in the perinatal period. Curr Opin Pediatr. 2021;33(2):181-187. doi: 10.1097/MOP.0000000000001004.
  • Edlow AG, Li JZ, Collier AY, Atyeo C, James KE, Boatin AA, et al. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic. JAMA Netw Open. 2020;3(12):e2030455. doi: 10.1001/jamanetworkopen.2020.30455.
  • Vogel JP, Chawanpaiboon S, Moller AB, Watananirun K, Bonet M, Lumbiganon P. The global epidemiology of preterm birth. Best Pract Res Clin Obstet Gynaecol. 2018;52:3-12. doi: 10.1016/j.bpobgyn.2018.04.003.
  • Martinez-Perez O, Prats Rodriguez P, Muner Hernandez M, The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis. BMC Pregnancy Childbirth. 2021;21(1):273. doi: 10.1186/s12884-021-03742-4.
  • Villar J, Ariff S, Gunier RB, Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021; e211050. doi: 10.1001/jamapediatrics.2021.1050.
  • Carrasco I, Muñoz-Chapuli M, Vigil-Vázquez S, SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during thefirst wave. BMC Pregnancy Childbirth. 2021;21(1):326. doi: 10.1186/s12884-021-03784-8.
  • Jering KS, Claggett BL, Cunningham JW, Rosenthal N, Vardeny O, Greene MF, Solomon SD. Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. JAMA Intern Med. 2021;181(5):714-717. doi: 10.1001/jamainternmed.2020.9241.
  • Steffen HA, Swartz SR, Jackson JB, Kenne KA, Ten Eyck PP, Merryman AS, Castaneda CN, Marsden K, Maxwell T, Merrill AE, Krasowski MD, Rysavy MB. SARS-CoV-2 Infection during Pregnancy in a Rural Midwest All-delivery Cohort and Associated Maternal and Neonatal Outcomes. Am J Perinatol. 2021;38(6):614-621. doi: 10.1055/s-0041-1723938.
  • Pineles BL, Alamo IC, Farooq N, Green J, Blackwell SC, Sibai BM, Parchem JG. Racial-ethnic disparities and pregnancy outcomes in SARS-CoV-2 infection in a universally-tested cohort in Houston, Texas. Eur J Obstet Gynecol Reprod Biol. 2020;254:329-330. doi: 10.1016/j.ejogrb.2020.09.012.
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65-94. doi: 10.7326/0003-4819-151-4-200908180-00136.
  • Hcini N, Maamri F, Picone O, Carod JF, Lambert V, Mathieu M, Carles G, Pomar L. Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study. Eur J Obstet Gynecol Reprod Biol. 2021;257:11-18. doi: 10.1016/j.ejogrb.2020.11.068.
  • Prabhu M, Cagino K, Matthews KC, Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. BJOG. 2020;127(12):1548-1556. doi: 10.1111/1471-0528.16403. Epub 2020 Aug 13.
  • Smithgall MC, Liu-Jarin X, Hamele-Bena D, Cimic A, Mourad M, Debelenko L, Chen X. Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization. Histopathology. 2020;77(6):994-999. doi: 10.1111/his.14215. Epub 2020 Sep 26.
  • Díaz-Corvillón P, Mönckeberg M, Barros A, Illanes SE, Soldati A, Nien JK, Schepeler M, Caradeux J. Routine screening for SARS CoV-2 in unselected pregnant women at delivery. PLoS One. 2020;15(9):e0239887. doi: 10.1371/journal.pone.0239887.
  • Brandt JS, Hill J, Reddy A, Schuster M, Patrick HS, Rosen T, Sauer MV, Boyle C, Ananth CV. Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes. Am J Obstet Gynecol. 2021;224(4):389.e1-389.e9. doi: 10.1016/j.ajog.2020.09.043. Epub 2020 Sep 25.
  • Flaherman VJ, Afshar Y, Boscardin J, Keller RL, Mardy A, Prahl MK, Phillips C, Asiodu IV, Berghella WV, Chambers BD, Crear-Perry J, Jamieson DJ, Jacoby VL, Gaw SL. Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study. Clin Infect Dis. 2020; ciaa1411. doi: 10.1093/cid/ciaa1411.
  • Li N, Han L, Peng M, Lv Y, Ouyang Y, Liu K, Yue L, Li Q, Sun G, Chen L, Yang L. Maternal and Neonatal Outcomes of Pregnant Women With Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case-Control Study. Clin Infect Dis. 2020; 71(16):2035-2041. doi: 10.1093/cid/ciaa352.
  • Maraschini A, Corsi E, Salvatore MA, Donati S; ItOSS COVID-19 Working Group. Coronavirus and birth in Italy: results of a national population-based cohort study. Ann Ist Super Sanita. 2020; 56(3):378-389. doi: 10.4415/ANN_20_03_17.
  • Nayak AH, Kapote DS, Fonseca M, Chavan N, Mayekar R, Sarmalkar M, Bawa A. Impact of the Coronavirus Infection in Pregnancy: A Preliminary Study of 141 Patients. J Obstet Gynaecol India. 2020; 70(4):256-261. doi: 10.1007/s13224-020-01335-3.
  • Pirjani R, Hosseini R, Soori T, Rabiei M, Hosseini L, Abiri A, Moini A, Shizarpour A, Razani G, Sepidarkish M. Maternal and neonatal outcomes in COVID-19 infected pregnancies: a prospective cohort study. J Travel Med. 2020; 27(7):taaa158. doi: 10.1093/jtm/taaa158.
  • Wang MJ, Schapero M, Iverson R, Yarrington CD. Obstetric Hemorrhage Risk Associated with Novel COVID-19 Diagnosis from a Single-Institution Cohort in the United States. Am J Perinatol. 2020; 37(14):1411-1416. doi: 10.1055/s-0040-1718403.
  • Patberg ET, Adams T, Rekawek P, Vahanian SA, Akerman M, Hernandez A, Rapkiewicz AV, Ragolia L, Sicuranza G, Chavez MR, Vintzileos AM, Khullar P. Coronavirus disease 2019 infection and placental histopathology in women delivering at term. Am J Obstet Gynecol. 2021;224(4):382.e1-382.e18. doi: 10.1016/j.ajog.2020.10.020.
  • Yang R, Mei H, Zheng T, Fu Q, Zhang Y, Buka S, Yao X, Tang Z, Zhang X, Qiu L, Zhang Y, Zhou J, Cao J, Wang Y, Zhou A. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China. BMC Med. 2020;18(1):330. doi: 10.1186/s12916-020-01798-1.
  • Ahlberg M, Neovius M, Saltvedt S, Söderling J, Pettersson K, Brandkvist C, Stephansson O. Association of SARS-CoV-2 Test Status and Pregnancy Outcomes. JAMA. 2020;324(17):1782-1785. doi: 10.1001/jama.2020.19124.
  • Cuñarro-López Y, Cano-Valderrama Ó, Pintado-Recarte P, Cueto-Hernández I, González-Garzón B, García-Tizón S, Bujan J, Asúnsolo Á, Ortega MA, De León-Luis JA. Maternal and Perinatal Outcomes in Patients with Suspected COVID-19 and Their Relationship with a Negative RT-PCR Result. J Clin Med. 2020;9(11):3552. doi: 10.3390/jcm9113552.
  • Woodworth KR, Olsen EO, Neelam V, Lewis EL, Galang RR, Oduyebo T, Aveni K, Yazdy MM, Harvey E, Longcore ND, Barton J, Fussman C, Siebman S, Lush M, Patrick PH, Halai UA, Valencia-Prado M, Orkis L, Sowunmi S, Schlosser L, Khuwaja S, Read JS, Hall AJ, Meaney-Delman D, Ellington SR, Gilboa SM, Tong VT; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team; COVID-19 Pregnancy and Infant Linked Outcomes Team (PILOT). Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1635-1640. doi: 10.15585/mmwr.mm6944e2.
  • Yazihan N, Tanacan A, Erol SA, Anuk AT, Sinaci S, Biriken D, Keskin HL, Moraloglu OT, Sahin D. Comparison of VEGF-A values between pregnant women with COVID-19 and healthy pregnancies and its association with composite adverse outcomes. J Med Virol. 2021;93(4):2204-2209. doi: 10.1002/jmv.26631.
  • Adhikari EH, Moreno W, Zofkie AC, MacDonald L, McIntire DD, Collins RRJ, Spong CY. Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection. JAMA Netw Open. 2020;3(11):e2029256. doi: 10.1001/jamanetworkopen.2020.29256.
  • Edlow AG, Li JZ, Collier AY, Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic. JAMA Netw Open. 2020;3(12):e2030455.doi: 10.1001/jamanetworkopen.2020.30455.
  • Erol SA, Tanacan A, Anuk AT, Evaluation of maternal serum afamin and vitamin E levels in pregnant women with COVID-19 and its association with composite adverse perinatal outcomes. J Med Virol. 2021;93(4):2350-2358. doi: 10.1002/jmv.26725.
  • Huntley BJF, Mulder IA, Di Mascio D, Vintzileos WS, Vintzileos AM, Berghella V, Chauhan SP. Adverse Pregnancy Outcomes Among Individuals With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review and Meta-analysis. Obstet Gynecol. 2021;137(4):585-596. doi: 10.1097/AOG.0000000000004320.
  • Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021;193(16):E540-E548. doi: 10.1503/cmaj.202604.
  • Patberg ET, Adams T, Rekawek P, et al. COVID-19 infection and placental histo- pathology in women delivering at term. Am J Obstet Gynecol. 2020; [Epub ahead of print];S0002-9378(20)31194-7. doi: 10.1016/j.ajog.2020.10.020.
  • Tasca C, Rossi RS, Corti S, et al. Placental Pathology in COVID-19 Affected Pregnant Women: a Prospective Case-Control Study [published online ahead of print, 2021 May 5]. Placenta. 2021;doi:10.1016/j.placenta.2021.04.002